Showing results (141-150 of 201) with videos related to

Sort By:
Pageof 21
European Journal of Haematology|July 18, 2023
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remissionTommy Alfaro Moya, Jonas Mattsson, Mats Remberger, et al.
Transplantation and Cellular Therapy|March 10, 2024
Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell TransplantationAyman Sayyed, Carol Chen, Armin Gerbitz, et al.
European Journal of Haematology|December 14, 2021
Anti-thymocyte Globulin and Post-Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen-A and -B mismatched donorsIgor Novitzky-Basso, Mats Remberger, Carol Chen, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 6, 2021
Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant PatientsEshrak Al-Shaibani, Rhida Bautista, Jeffrey H Lipton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2017
Long-Term Incidence of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplantation: A Single-Center ExperienceFotios V Michelis, Rouslan Kotchetkov, Rebecca M Grunwald, et al.
Blood|January 31, 2013
Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasmsJames A Kennedy, Eshetu G Atenafu, Hans A Messner, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 8, 2021
Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute LeukemiaEshrak Al-Shaibani, Sunu Cyriac, Shiyi Chen, et al.
European Journal of Haematology|June 2, 2021
Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CRIgor Novitzky-Basso, Carol Chen, Shiyi Chen, et al.
Leukemia & Lymphoma|May 14, 2026
CMV reactivation post allogeneic stem cell transplantation decreases relapse risk and survival, and increases NRM - a single center analysisVered Stavi, Carol Chen, Igor Novitzky-Basso, et al.
Annals of Hematology|February 23, 2023
Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experienceEshrak Al-Shaibani, Shiyi Chen, Carol Chen, et al.
Pageof 21